 Zachary Watson
Concepts (111)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ovarian Neoplasms | 8 | 2024 | 484 | 1.750 |
Why?
| | Herpesvirus 1, Human | 5 | 2018 | 86 | 1.640 |
Why?
| | Poly(ADP-ribose) Polymerase Inhibitors | 6 | 2024 | 90 | 1.280 |
Why?
| | Virus Latency | 3 | 2018 | 84 | 1.010 |
Why?
| | Gene Expression Regulation, Viral | 3 | 2018 | 90 | 1.000 |
Why?
| | Cystadenocarcinoma, Serous | 3 | 2023 | 68 | 0.980 |
Why?
| | Genetic Vectors | 4 | 2019 | 314 | 0.820 |
Why?
| | Dependovirus | 3 | 2019 | 63 | 0.800 |
Why?
| | Phthalazines | 2 | 2019 | 41 | 0.790 |
Why?
| | Histone-Lysine N-Methyltransferase | 2 | 2024 | 124 | 0.780 |
Why?
| | Piperazines | 2 | 2019 | 340 | 0.680 |
Why?
| | Histocompatibility Antigens | 2 | 2024 | 107 | 0.680 |
Why?
| | Drug Resistance, Neoplasm | 5 | 2024 | 752 | 0.670 |
Why?
| | Transduction, Genetic | 2 | 2019 | 131 | 0.650 |
Why?
| | Virus Activation | 2 | 2018 | 88 | 0.610 |
Why?
| | Protein-Arginine N-Methyltransferases | 1 | 2019 | 28 | 0.610 |
Why?
| | RNA, Long Noncoding | 1 | 2018 | 179 | 0.500 |
Why?
| | Sensory Receptor Cells | 1 | 2016 | 103 | 0.480 |
Why?
| | Polycomb-Group Proteins | 2 | 2023 | 28 | 0.470 |
Why?
| | RNA, Viral | 1 | 2018 | 620 | 0.460 |
Why?
| | Cell Line, Tumor | 7 | 2024 | 3186 | 0.360 |
Why?
| | Host-Pathogen Interactions | 1 | 2013 | 356 | 0.330 |
Why?
| | Rabbits | 4 | 2019 | 779 | 0.320 |
Why?
| | Neoplasms | 2 | 2023 | 2455 | 0.300 |
Why?
| | Trigeminal Ganglion | 2 | 2019 | 25 | 0.280 |
Why?
| | Ganglia, Spinal | 2 | 2019 | 75 | 0.280 |
Why?
| | Herpes Simplex | 2 | 2018 | 92 | 0.260 |
Why?
| | Histones | 2 | 2023 | 589 | 0.260 |
Why?
| | Mice | 9 | 2024 | 16961 | 0.210 |
Why?
| | Polycomb Repressive Complex 1 | 1 | 2023 | 48 | 0.200 |
Why?
| | Animals | 12 | 2024 | 35391 | 0.200 |
Why?
| | Tumor Microenvironment | 2 | 2023 | 627 | 0.170 |
Why?
| | Cytoreduction Surgical Procedures | 1 | 2020 | 59 | 0.170 |
Why?
| | Xenograft Model Antitumor Assays | 2 | 2020 | 808 | 0.170 |
Why?
| | Epoxy Compounds | 1 | 2020 | 33 | 0.170 |
Why?
| | Carnitine O-Palmitoyltransferase | 1 | 2020 | 45 | 0.160 |
Why?
| | Rad51 Recombinase | 1 | 2019 | 13 | 0.160 |
Why?
| | BRCA2 Protein | 1 | 2019 | 54 | 0.160 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2020 | 377 | 0.160 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 2019 | 94 | 0.160 |
Why?
| | Neoplasm Grading | 1 | 2019 | 282 | 0.150 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2024 | 855 | 0.150 |
Why?
| | CCCTC-Binding Factor | 1 | 2018 | 14 | 0.150 |
Why?
| | Oncogenes | 1 | 2019 | 110 | 0.150 |
Why?
| | Neoadjuvant Therapy | 1 | 2020 | 379 | 0.140 |
Why?
| | Gene Knockout Techniques | 1 | 2018 | 109 | 0.140 |
Why?
| | Gene Transfer Techniques | 1 | 2019 | 161 | 0.140 |
Why?
| | RNA, Catalytic | 1 | 2018 | 185 | 0.140 |
Why?
| | Sequence Analysis, RNA | 1 | 2019 | 427 | 0.140 |
Why?
| | Carcinogenesis | 1 | 2019 | 213 | 0.140 |
Why?
| | Fatty Acids | 1 | 2020 | 427 | 0.130 |
Why?
| | Up-Regulation | 1 | 2020 | 840 | 0.130 |
Why?
| | Parvoviridae Infections | 1 | 2016 | 11 | 0.130 |
Why?
| | Mass Spectrometry | 1 | 2019 | 714 | 0.130 |
Why?
| | Eye | 1 | 2016 | 105 | 0.120 |
Why?
| | Foot | 1 | 2016 | 93 | 0.120 |
Why?
| | Coinfection | 1 | 2016 | 131 | 0.120 |
Why?
| | Female | 10 | 2024 | 68734 | 0.110 |
Why?
| | Mice, Transgenic | 1 | 2019 | 2128 | 0.100 |
Why?
| | Gene Expression Profiling | 1 | 2019 | 1687 | 0.100 |
Why?
| | Disease Progression | 1 | 2019 | 2627 | 0.100 |
Why?
| | Anoikis | 2 | 2023 | 31 | 0.100 |
Why?
| | Transcription, Genetic | 1 | 2018 | 1418 | 0.090 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 1560 | 0.090 |
Why?
| | Humans | 11 | 2024 | 129626 | 0.090 |
Why?
| | Cells, Cultured | 1 | 2018 | 4084 | 0.090 |
Why?
| | Neurons | 1 | 2018 | 1494 | 0.080 |
Why?
| | Inflammation | 1 | 2020 | 2750 | 0.080 |
Why?
| | Cornea | 2 | 2019 | 128 | 0.070 |
Why?
| | Genetic Therapy | 1 | 2009 | 289 | 0.070 |
Why?
| | Central Nervous System | 1 | 2009 | 255 | 0.070 |
Why?
| | Breast Neoplasms | 1 | 2019 | 2133 | 0.070 |
Why?
| | Antineoplastic Agents | 1 | 2017 | 2046 | 0.060 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2020 | 1336 | 0.050 |
Why?
| | Lysine | 1 | 2023 | 286 | 0.040 |
Why?
| | ErbB Receptors | 1 | 2023 | 607 | 0.040 |
Why?
| | Gene Knockdown Techniques | 1 | 2020 | 317 | 0.040 |
Why?
| | Indazoles | 1 | 2019 | 66 | 0.040 |
Why?
| | Heterografts | 1 | 2019 | 133 | 0.040 |
Why?
| | Ganglia | 1 | 2018 | 17 | 0.040 |
Why?
| | Injections | 1 | 2019 | 174 | 0.040 |
Why?
| | Virus Shedding | 1 | 2018 | 48 | 0.040 |
Why?
| | 3T3 Cells | 1 | 2018 | 154 | 0.040 |
Why?
| | Transgenes | 1 | 2019 | 177 | 0.040 |
Why?
| | Fluorescent Antibody Technique | 1 | 2019 | 376 | 0.040 |
Why?
| | Cell Culture Techniques | 1 | 2020 | 338 | 0.040 |
Why?
| | RNA, Small Interfering | 1 | 2020 | 591 | 0.040 |
Why?
| | Peptides | 1 | 2023 | 926 | 0.040 |
Why?
| | Wnt Signaling Pathway | 1 | 2019 | 170 | 0.030 |
Why?
| | Piperidines | 1 | 2019 | 201 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2020 | 1203 | 0.030 |
Why?
| | Genome, Viral | 1 | 2018 | 128 | 0.030 |
Why?
| | Indoles | 1 | 2019 | 383 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2020 | 1028 | 0.030 |
Why?
| | Survival Rate | 1 | 2020 | 1872 | 0.030 |
Why?
| | Transcription Factors | 1 | 2023 | 1647 | 0.030 |
Why?
| | Binding Sites | 1 | 2018 | 1248 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2019 | 1685 | 0.030 |
Why?
| | Gene Expression | 1 | 2019 | 1465 | 0.030 |
Why?
| | Prognosis | 1 | 2020 | 3774 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2020 | 4894 | 0.020 |
Why?
| | Genes, Immediate-Early | 1 | 2009 | 20 | 0.020 |
Why?
| | Lac Operon | 1 | 2009 | 45 | 0.020 |
Why?
| | Microinjections | 1 | 2009 | 86 | 0.020 |
Why?
| | CD11c Antigen | 1 | 2009 | 41 | 0.020 |
Why?
| | CD11b Antigen | 1 | 2009 | 61 | 0.020 |
Why?
| | Mutation | 1 | 2019 | 3717 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2018 | 4078 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 949 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2009 | 756 | 0.020 |
Why?
| | Virus Replication | 1 | 2009 | 452 | 0.020 |
Why?
|
|
Watson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|